1. Home
  2. BHIL vs NKGN Comparison

BHIL vs NKGN Comparison

Compare BHIL & NKGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BHIL
  • NKGN
  • Stock Information
  • Founded
  • BHIL 2012
  • NKGN 2017
  • Country
  • BHIL United States
  • NKGN United States
  • Employees
  • BHIL N/A
  • NKGN N/A
  • Industry
  • BHIL Packaged Foods
  • NKGN Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • BHIL Consumer Staples
  • NKGN Health Care
  • Exchange
  • BHIL Nasdaq
  • NKGN Nasdaq
  • Market Cap
  • BHIL 34.9M
  • NKGN 24.1M
  • IPO Year
  • BHIL N/A
  • NKGN N/A
  • Fundamental
  • Price
  • BHIL $7.00
  • NKGN $1.17
  • Analyst Decision
  • BHIL Hold
  • NKGN
  • Analyst Count
  • BHIL 1
  • NKGN 0
  • Target Price
  • BHIL N/A
  • NKGN N/A
  • AVG Volume (30 Days)
  • BHIL 87.0K
  • NKGN 2.3M
  • Earning Date
  • BHIL 08-07-2024
  • NKGN 08-16-2024
  • Dividend Yield
  • BHIL N/A
  • NKGN N/A
  • EPS Growth
  • BHIL N/A
  • NKGN N/A
  • EPS
  • BHIL N/A
  • NKGN N/A
  • Revenue
  • BHIL $359,826,000.00
  • NKGN N/A
  • Revenue This Year
  • BHIL N/A
  • NKGN N/A
  • Revenue Next Year
  • BHIL $1.62
  • NKGN N/A
  • P/E Ratio
  • BHIL N/A
  • NKGN N/A
  • Revenue Growth
  • BHIL N/A
  • NKGN N/A
  • 52 Week Low
  • BHIL $4.41
  • NKGN $0.78
  • 52 Week High
  • BHIL $55.30
  • NKGN $6.70
  • Technical
  • Relative Strength Index (RSI)
  • BHIL 59.58
  • NKGN 48.72
  • Support Level
  • BHIL $5.78
  • NKGN $0.87
  • Resistance Level
  • BHIL $7.10
  • NKGN $1.36
  • Average True Range (ATR)
  • BHIL 0.49
  • NKGN 0.15
  • MACD
  • BHIL 0.10
  • NKGN 0.02
  • Stochastic Oscillator
  • BHIL 94.49
  • NKGN 59.68

About BHIL Benson Hill Inc.

Benson Hill Inc is an ag-tech company specializing in soy protein innovation. The company has one business segment Ingredient. The company focuses on seed innovation through proprietary germplasm and the CropOS platform. This platform integrates protein, genomic, and strategic data for predictive breeding using AI and ML. They operate a Crop Accelerator for rapid prototyping. Benson Hill is developing a seed portfolio for protein ingredients, aquaculture, specialty animal feed, and vegetable oils. The company's revenue can be disaggregated into product categories: Proprietary and Non-Proprietary. Proprietary revenue is defined as any sale of a proprietary bean. Non-Proprietary revenue is all other revenue from non-Proprietary sources.

About NKGN NKGen Biotech Inc.

NKGen Biotech Inc is a biotechnology company developing cell therapies for neurodegenerative and oncological diseases based on activated NK cells. NK cells are part of the human innate immune response system that can selectively identify and destroy abnormal or diseased cells. Its product candidates are based on a proprietary manufacturing and cryopreservation process that produces SuperNKTM (SNK) cells that have shown increased activity as compared to the starting population of NK cells, based on the results of in vitro experiments performed by NKMAX, as defined by parameters such as cytotoxicity, cytokine production and activating receptor expression. SNK cells can be produced in large quantities and cryopreserved while maintaining high levels of cytotoxicity.

Share on Social Networks: